Claire Barton

4.1k total citations · 1 hit paper
40 papers, 2.7k citations indexed

About

Claire Barton is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Claire Barton has authored 40 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 10 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Claire Barton's work include HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (9 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Claire Barton is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Cancer Treatment and Pharmacology (9 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Claire Barton collaborates with scholars based in United Kingdom, United States and Italy. Claire Barton's co-authors include Nicholas R. Lemoine, Parviz Ghahramani, William J. Gullick, Christine M. Hughes, Luca Gianni, José Baselga, Peter A. Hall, Miguel Ángel Climent, Eva Ciruelos and A. Feyereislova and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Claire Barton

38 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

2010 891 citations Claire Barton et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claire Barton United Kingdom	19	2.0k	828	689	625	519	40	2.7k
Marta Guix Spain	17	1.4k 0.7×	599 0.7×	398 0.6×	1.1k 1.8×	714 1.4×	43	2.5k
Arlene Berman United States	22	1.3k 0.6×	534 0.6×	284 0.4×	614 1.0×	474 0.9×	47	2.4k
Vincenzo Damiano Italy	26	1.9k 0.9×	459 0.6×	336 0.5×	1.4k 2.2×	1.2k 2.2×	62	3.2k
G. Deplanque France	23	1.3k 0.6×	542 0.7×	221 0.3×	633 1.0×	812 1.6×	77	2.3k
Xiaochun Fei China	27	874 0.4×	764 0.9×	456 0.7×	634 1.0×	384 0.7×	90	2.2k
K. Hacène France	26	1.7k 0.8×	1.2k 1.5×	301 0.4×	881 1.4×	661 1.3×	76	3.2k
Cammie Rinehart United States	15	1.7k 0.8×	327 0.4×	719 1.0×	1.7k 2.7×	567 1.1×	19	2.8k
Volker Möbus Germany	26	1.2k 0.6×	587 0.7×	246 0.4×	493 0.8×	312 0.6×	117	2.2k
John C. Araujo United States	25	1.1k 0.5×	567 0.7×	509 0.7×	851 1.4×	1.4k 2.8×	89	2.5k
In Ae Park South Korea	28	1.1k 0.5×	1.1k 1.3×	480 0.7×	609 1.0×	310 0.6×	72	2.6k

Countries citing papers authored by Claire Barton

Since Specialization

Citations

This map shows the geographic impact of Claire Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Barton more than expected).

Fields of papers citing papers by Claire Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Barton. The network helps show where Claire Barton may publish in the future.

Co-authorship network of co-authors of Claire Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Barton. A scholar is included among the top collaborators of Claire Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Barton. Claire Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barton, Claire, et al.. (2024). An eMERGEing definition of patient engagement in genetic counseling. Journal of Genetic Counseling. 34(3). e2001–e2001.

Young, Jennifer L., et al.. (2024). Family health beliefs and cascade genetic testing in Asian families with hereditary cancer risk: “Okay, now what?”. Journal of Genetic Counseling. 34(1). e1891–e1891. 1 indexed citations

Bines, José, Emma Clark, Claire Barton, et al.. (2021). Patient-reported function, health-related quality of life, and symptoms in APHINITY: pertuzumab plus trastuzumab and chemotherapy in HER2-positive early breast cancer. British Journal of Cancer. 125(1). 38–47. 5 indexed citations

Bax, Heather J., Jitesh Chauhan, Chara Stavraka, et al.. (2020). Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome. Cells. 9(7). 1631–1631. 31 indexed citations

Woodcock, Victoria K., Sally Clive, Richard H. Wilson, et al.. (2018). A first-in-human phase I study to determine the maximum tolerated dose of the oral Src/ABL inhibitor AZD0424. British Journal of Cancer. 118(6). 770–776. 10 indexed citations

Wong, Han Hsi, et al.. (2016). Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience. European Journal of Cancer. 66. 9–16. 15 indexed citations

Barton, Claire, Robert G. Scott, Paul S. Jones, et al.. (2016). Beta-glucan contamination of pharmaceutical products: How much should we accept?. Cancer Immunology Immunotherapy. 65(11). 1289–1301. 40 indexed citations

Baselga, José, Xavier Carbonell, Michael Clemens, et al.. (2005). Phase II Study of Efficacy, Safety, and Pharmacokinetics of Trastuzumab Monotherapy Administered on a 3-Weekly Schedule. Journal of Clinical Oncology. 23(10). 2162–2171. 306 indexed citations

Suter, Thomas, Nancy Cook‐Bruns, & Claire Barton. (2003). Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer. The Breast. 13(3). 173–183. 115 indexed citations

10.

Waxman, Jonathan & Claire Barton. (1993). Carboplatin-based chemotherapy for bladder cancer. Cancer Treatment Reviews. 19. 21–25. 43 indexed citations

11.

Wyllie, Fiona S., et al.. (1993). Direct growth stimulation of normal human epithelial cells by mutant p53. Molecular Carcinogenesis. 7(2). 83–88. 28 indexed citations

12.

Stein, Robert C., Mark Bower, Matthew Law, et al.. (1992). Mitozantrone and methotrexate chemotherapy with and without mitomycin C in the treatment of advanced breast cancer: a randomised clinical trial. European Journal of Cancer. 28(12). 1963–1965. 7 indexed citations

13.

Lemoine, Nicholas R., Christine M. Hughes, Claire Barton, et al.. (1992). The epidermal growth factor receptor in human pancreatic cancer. The Journal of Pathology. 166(1). 7–12. 153 indexed citations

14.

Waxman, Jonathan, Claire Barton, Nicholas D. James, et al.. (1992). Bladder Cancer: Inter‐relationships between Chemotherapy and Radiotherapy. British Journal of Urology. 69(2). 151–155. 5 indexed citations

15.

Barton, Claire, Peter A. Hall, Christine M. Hughes, William J. Gullick, & Nicholas R. Lemoine. (1991). Transforming growth factor alpha and epidermal growth factor in human pancreatic cancer. The Journal of Pathology. 163(2). 111–116. 163 indexed citations

16.

Barton, Claire & Jonathan Waxman. (1990). Effects of chemotherapy on fertility. Blood Reviews. 4(3). 187–195. 23 indexed citations

17.

Groundwater, Paul W., et al.. (1990). Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. British Journal of Cancer. 62(5). 816–821. 45 indexed citations

18.

Barton, Claire, E. J. Buxton, G. Blackledge, J. Mould, & C. A. Meanwell. (1990). A phase II study of ifosfamide in endometrial cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S4–S6. 16 indexed citations

19.

Barton, Claire, Gillian Duchesne, M. V. Williams, Cyril Fisher, & A. Horwich. (1988). The impact of hydronephrosis on renal function in patients treated with cisplatin-based chemotherapy for metastatic nonseminomatous germ cell tumors. Cancer. 62(7). 1439–1443. 7 indexed citations

20.

Barton, Claire. (1968). Experiences of a Poison Information Center Director. Clinical toxicology. 1(1). 87–90.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact